aluates Reports

$ 0.0

Automative

Global Drugs for PNH Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-10L18431

BUY CHAPTERS

Global Drugs for PNH Market Research Report 2024

Code: QYRE-Auto-10L18431

Report

October 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Alexion Pharmaceuticals

Roche

Apellis Pharmaceuticals

Amgen Inc

Samsung Bioepis

Drugs for PNH Market

Drugs for paroxysmal nocturnal hemoglobinuria (PNH) primarily include complement inhibitors that block the destruction of red blood cells. The most common drugs are Eculizumab and Ravulizumab, both of which target complement protein C5 to prevent the formation of the membrane attack complex (MAC), reducing hemolysis, thrombosis risk, and other PNH complications. These drugs are typically administered via intravenous infusion and have significantly improved outcomes for PNH patients.

The global Drugs for PNH market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Drugs for PNH is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Drugs for PNH is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Drugs for PNH include Novartis, Alexion Pharmaceuticals, Roche, Apellis Pharmaceuticals, Amgen, Samsung Bioepis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for PNH, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for PNH.

The Drugs for PNH market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs for PNH market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for PNH manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drugs for PNH Market Report

Report Metric	Details
Report Name	Drugs for PNH Market
Segment by Type	Complement Inhibitors Others
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Alexion Pharmaceuticals, Roche, Apellis Pharmaceuticals, Amgen, Samsung Bioepis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for PNH manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for PNH in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs for PNH Market report?

Ans: The main players in the Drugs for PNH Market are Novartis, Alexion Pharmaceuticals, Roche, Apellis Pharmaceuticals, Amgen, Samsung Bioepis

What are the Application segmentation covered in the Drugs for PNH Market report?

Ans: The Applications covered in the Drugs for PNH Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Drugs for PNH Market report?

Ans: The Types covered in the Drugs for PNH Market report are Complement Inhibitors, Others

Recommended Reports

Anemia and Hematology

Kidney and Blood

Rare Disease Drugs

1 Drugs for PNH Market Overview

1.1 Product Definition

1.2 Drugs for PNH by Type

1.2.1 Global Drugs for PNH Market Value Comparison by Type (2024-2030)

1.2.2 Complement Inhibitors

1.2.3 Others

1.3 Drugs for PNH by Application

1.3.1 Global Drugs for PNH Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Drugs for PNH Market Size Estimates and Forecasts

1.4.1 Global Drugs for PNH Revenue 2019-2030

1.4.2 Global Drugs for PNH Sales 2019-2030

1.4.3 Global Drugs for PNH Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Drugs for PNH Market Competition by Manufacturers

2.1 Global Drugs for PNH Sales Market Share by Manufacturers (2019-2024)

2.2 Global Drugs for PNH Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Drugs for PNH Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Drugs for PNH, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Drugs for PNH, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Drugs for PNH, Product Type & Application

2.7 Global Key Manufacturers of Drugs for PNH, Date of Enter into This Industry

2.8 Global Drugs for PNH Market Competitive Situation and Trends

2.8.1 Global Drugs for PNH Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Drugs for PNH Players Market Share by Revenue

2.8.3 Global Drugs for PNH Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drugs for PNH Market Scenario by Region

3.1 Global Drugs for PNH Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Drugs for PNH Sales by Region: 2019-2030

3.2.1 Global Drugs for PNH Sales by Region: 2019-2024

3.2.2 Global Drugs for PNH Sales by Region: 2025-2030

3.3 Global Drugs for PNH Revenue by Region: 2019-2030

3.3.1 Global Drugs for PNH Revenue by Region: 2019-2024

3.3.2 Global Drugs for PNH Revenue by Region: 2025-2030

3.4 North America Drugs for PNH Market Facts & Figures by Country

3.4.1 North America Drugs for PNH Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Drugs for PNH Sales by Country (2019-2030)

3.4.3 North America Drugs for PNH Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Drugs for PNH Market Facts & Figures by Country

3.5.1 Europe Drugs for PNH Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Drugs for PNH Sales by Country (2019-2030)

3.5.3 Europe Drugs for PNH Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drugs for PNH Market Facts & Figures by Region

3.6.1 Asia Pacific Drugs for PNH Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Drugs for PNH Sales by Region (2019-2030)

3.6.3 Asia Pacific Drugs for PNH Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Drugs for PNH Market Facts & Figures by Country

3.7.1 Latin America Drugs for PNH Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Drugs for PNH Sales by Country (2019-2030)

3.7.3 Latin America Drugs for PNH Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Drugs for PNH Market Facts & Figures by Country

3.8.1 Middle East and Africa Drugs for PNH Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Drugs for PNH Sales by Country (2019-2030)

3.8.3 Middle East and Africa Drugs for PNH Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Drugs for PNH Sales by Type (2019-2030)

4.1.1 Global Drugs for PNH Sales by Type (2019-2024)

4.1.2 Global Drugs for PNH Sales by Type (2025-2030)

4.1.3 Global Drugs for PNH Sales Market Share by Type (2019-2030)

4.2 Global Drugs for PNH Revenue by Type (2019-2030)

4.2.1 Global Drugs for PNH Revenue by Type (2019-2024)

4.2.2 Global Drugs for PNH Revenue by Type (2025-2030)

4.2.3 Global Drugs for PNH Revenue Market Share by Type (2019-2030)

4.3 Global Drugs for PNH Price by Type (2019-2030)

5 Segment by Application

5.1 Global Drugs for PNH Sales by Application (2019-2030)

5.1.1 Global Drugs for PNH Sales by Application (2019-2024)

5.1.2 Global Drugs for PNH Sales by Application (2025-2030)

5.1.3 Global Drugs for PNH Sales Market Share by Application (2019-2030)

5.2 Global Drugs for PNH Revenue by Application (2019-2030)

5.2.1 Global Drugs for PNH Revenue by Application (2019-2024)

5.2.2 Global Drugs for PNH Revenue by Application (2025-2030)

5.2.3 Global Drugs for PNH Revenue Market Share by Application (2019-2030)

5.3 Global Drugs for PNH Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis Drugs for PNH Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Alexion Pharmaceuticals

6.2.1 Alexion Pharmaceuticals Company Information

6.2.2 Alexion Pharmaceuticals Description and Business Overview

6.2.3 Alexion Pharmaceuticals Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Alexion Pharmaceuticals Drugs for PNH Product Portfolio

6.2.5 Alexion Pharmaceuticals Recent Developments/Updates

6.3 Roche

6.3.1 Roche Company Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Roche Drugs for PNH Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Apellis Pharmaceuticals

6.4.1 Apellis Pharmaceuticals Company Information

6.4.2 Apellis Pharmaceuticals Description and Business Overview

6.4.3 Apellis Pharmaceuticals Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Apellis Pharmaceuticals Drugs for PNH Product Portfolio

6.4.5 Apellis Pharmaceuticals Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Company Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Amgen Drugs for PNH Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 Samsung Bioepis

6.6.1 Samsung Bioepis Company Information

6.6.2 Samsung Bioepis Description and Business Overview

6.6.3 Samsung Bioepis Drugs for PNH Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Samsung Bioepis Drugs for PNH Product Portfolio

6.6.5 Samsung Bioepis Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drugs for PNH Industry Chain Analysis

7.2 Drugs for PNH Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drugs for PNH Production Mode & Process

7.4 Drugs for PNH Sales and Marketing

7.4.1 Drugs for PNH Sales Channels

7.4.2 Drugs for PNH Distributors

7.5 Drugs for PNH Customers

8 Drugs for PNH Market Dynamics

8.1 Drugs for PNH Industry Trends

8.2 Drugs for PNH Market Drivers

8.3 Drugs for PNH Market Challenges

8.4 Drugs for PNH Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis

Alexion Pharmaceuticals

Roche

Apellis Pharmaceuticals

Amgen Inc

Samsung Bioepis

List of Tables

Table 1. Global Drugs for PNH Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Drugs for PNH Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Drugs for PNH Market Competitive Situation by Manufacturers in 2023

Table 4. Global Drugs for PNH Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Drugs for PNH Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Drugs for PNH Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Drugs for PNH Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Drugs for PNH Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Drugs for PNH, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Drugs for PNH, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Drugs for PNH, Product Type & Application

Table 12. Global Key Manufacturers of Drugs for PNH, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Drugs for PNH by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for PNH as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Drugs for PNH Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Drugs for PNH Sales by Region (2019-2024) & (K Units)

Table 18. Global Drugs for PNH Sales Market Share by Region (2019-2024)

Table 19. Global Drugs for PNH Sales by Region (2025-2030) & (K Units)

Table 20. Global Drugs for PNH Sales Market Share by Region (2025-2030)

Table 21. Global Drugs for PNH Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Drugs for PNH Revenue Market Share by Region (2019-2024)

Table 23. Global Drugs for PNH Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Drugs for PNH Revenue Market Share by Region (2025-2030)

Table 25. North America Drugs for PNH Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Drugs for PNH Sales by Country (2019-2024) & (K Units)

Table 27. North America Drugs for PNH Sales by Country (2025-2030) & (K Units)

Table 28. North America Drugs for PNH Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Drugs for PNH Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Drugs for PNH Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Drugs for PNH Sales by Country (2019-2024) & (K Units)

Table 32. Europe Drugs for PNH Sales by Country (2025-2030) & (K Units)

Table 33. Europe Drugs for PNH Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Drugs for PNH Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Drugs for PNH Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Drugs for PNH Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Drugs for PNH Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Drugs for PNH Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Drugs for PNH Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Drugs for PNH Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Drugs for PNH Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Drugs for PNH Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Drugs for PNH Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Drugs for PNH Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Drugs for PNH Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Drugs for PNH Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Drugs for PNH Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Drugs for PNH Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Drugs for PNH Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Drugs for PNH Sales (K Units) by Type (2019-2024)

Table 51. Global Drugs for PNH Sales (K Units) by Type (2025-2030)

Table 52. Global Drugs for PNH Sales Market Share by Type (2019-2024)

Table 53. Global Drugs for PNH Sales Market Share by Type (2025-2030)

Table 54. Global Drugs for PNH Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Drugs for PNH Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Drugs for PNH Revenue Market Share by Type (2019-2024)

Table 57. Global Drugs for PNH Revenue Market Share by Type (2025-2030)

Table 58. Global Drugs for PNH Price (US$/Unit) by Type (2019-2024)

Table 59. Global Drugs for PNH Price (US$/Unit) by Type (2025-2030)

Table 60. Global Drugs for PNH Sales (K Units) by Application (2019-2024)

Table 61. Global Drugs for PNH Sales (K Units) by Application (2025-2030)

Table 62. Global Drugs for PNH Sales Market Share by Application (2019-2024)

Table 63. Global Drugs for PNH Sales Market Share by Application (2025-2030)

Table 64. Global Drugs for PNH Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Drugs for PNH Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Drugs for PNH Revenue Market Share by Application (2019-2024)

Table 67. Global Drugs for PNH Revenue Market Share by Application (2025-2030)

Table 68. Global Drugs for PNH Price (US$/Unit) by Application (2019-2024)

Table 69. Global Drugs for PNH Price (US$/Unit) by Application (2025-2030)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Novartis Drugs for PNH Product

Table 74. Novartis Recent Developments/Updates

Table 75. Alexion Pharmaceuticals Company Information

Table 76. Alexion Pharmaceuticals Description and Business Overview

Table 77. Alexion Pharmaceuticals Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Alexion Pharmaceuticals Drugs for PNH Product

Table 79. Alexion Pharmaceuticals Recent Developments/Updates

Table 80. Roche Company Information

Table 81. Roche Description and Business Overview

Table 82. Roche Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Roche Drugs for PNH Product

Table 84. Roche Recent Developments/Updates

Table 85. Apellis Pharmaceuticals Company Information

Table 86. Apellis Pharmaceuticals Description and Business Overview

Table 87. Apellis Pharmaceuticals Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Apellis Pharmaceuticals Drugs for PNH Product

Table 89. Apellis Pharmaceuticals Recent Developments/Updates

Table 90. Amgen Company Information

Table 91. Amgen Description and Business Overview

Table 92. Amgen Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Amgen Drugs for PNH Product

Table 94. Amgen Recent Developments/Updates

Table 95. Samsung Bioepis Company Information

Table 96. Samsung Bioepis Description and Business Overview

Table 97. Samsung Bioepis Drugs for PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Samsung Bioepis Drugs for PNH Product

Table 99. Samsung Bioepis Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Drugs for PNH Distributors List

Table 103. Drugs for PNH Customers List

Table 104. Drugs for PNH Market Trends

Table 105. Drugs for PNH Market Drivers

Table 106. Drugs for PNH Market Challenges

Table 107. Drugs for PNH Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drugs for PNH

Figure 2. Global Drugs for PNH Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Drugs for PNH Market Share by Type: 2023 & 2030

Figure 4. Complement Inhibitors Product Picture

Figure 5. Others Product Picture

Figure 6. Global Drugs for PNH Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Drugs for PNH Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Drugs for PNH Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Drugs for PNH Market Size (2019-2030) & (US$ Million)

Figure 13. Global Drugs for PNH Sales (2019-2030) & (K Units)

Figure 14. Global Drugs for PNH Average Price (US$/Unit) & (2019-2030)

Figure 15. Drugs for PNH Report Years Considered

Figure 16. Drugs for PNH Sales Share by Manufacturers in 2023

Figure 17. Global Drugs for PNH Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Drugs for PNH Players: Market Share by Revenue in Drugs for PNH in 2023

Figure 19. Drugs for PNH Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Drugs for PNH Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Drugs for PNH Sales Market Share by Country (2019-2030)

Figure 22. North America Drugs for PNH Revenue Market Share by Country (2019-2030)

Figure 23. United States Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Drugs for PNH Sales Market Share by Country (2019-2030)

Figure 26. Europe Drugs for PNH Revenue Market Share by Country (2019-2030)

Figure 27. Germany Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Drugs for PNH Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Drugs for PNH Revenue Market Share by Region (2019-2030)

Figure 34. China Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Drugs for PNH Sales Market Share by Country (2019-2030)

Figure 42. Mexico Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Drugs for PNH Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Drugs for PNH Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Drugs for PNH Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Drugs for PNH by Type (2019-2030)

Figure 52. Global Revenue Market Share of Drugs for PNH by Type (2019-2030)

Figure 53. Global Drugs for PNH Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Drugs for PNH by Application (2019-2030)

Figure 55. Global Revenue Market Share of Drugs for PNH by Application (2019-2030)

Figure 56. Global Drugs for PNH Price (US$/Unit) by Application (2019-2030)

Figure 57. Drugs for PNH Value Chain

Figure 58. Drugs for PNH Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Complement Protein C3 Inhibitors Market Research Report 2024

Global Paroxysmal Nocturnal Hemoglobinuria PNH Treatment Market Research Report 2024

Global Eculizumab Market Research Report 2024

Global Complement Inhibitors Market Research Report 2024

Global Pegcetacoplan Injection Market Research Report 2024

Soliris Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Complement C5 Recombinant Monoclonal Antibody Market Research Report 2024

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025

Global Soliris Market Insights Forecast to 2030

Global Drugs for HAE Market Research Report 2024

Global PNH and aHUS Market Insights Forecast to 2030

Global Hydroxycarbamide Market Research Report 2025

Nocturnal Polyuria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HAE Treatments Market Research Report 2024

Global Pifithrin alpha Hydrobromide Market Research Report 2024

Panhematin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Methylmalonic Acidemia Treatment Medications Market Research Report 2024

Global Injectable Blood Thinners Market Research Report 2025

Global Drugs for Treating Hyperuricemia Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions